Maximum potential cost-savings attributable to generic substitution of antipsychotics 2008 to 2013
Background: Schizophrenia is a costly illness to treat, especially during a time of escalating medicine inflation costs, putting a large economic strain on patients, their families and the community. Treatment, however, can become more affordable through generic substitution. Objective: To determine...
Saved in:
Main Authors: | D. Husselmann (Author), R. Joubert (Author), J.R. Burger (Author), M.S. Lubbe (Author), M. Cockeran (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2016-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maximum potential cost-savings attributable to generic substitution of antipsychotics 2008 to 2013
by: D. Husselmann, et al.
Published: (2016) -
Further potential savings attributable to maximum generic substitution of antidepressants in South Africa: A retrospective analysis of medical claims
by: Elmarie van der Westhuizen, et al.
Published: (2010) -
Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005-2013
by: Liezl Joubert, et al.
Published: (2018) -
Carbamazepine Toxicity with Generic Substitution
by: J Gordon Millichap
Published: (1994) -
Generic Substitutions for Antiepileptic Drugs
by: J Gordon Millichap
Published: (1990)